Opioid Use Disorder
A problematic pattern of opioid use leading to clinically significant impairment or distress, reflected in a cluster of behavioral, physiological, and craving-related symptoms occurring within a 12-month period.
Both are substance use disorders defined by a problematic pattern of use leading to clinically significant impairment or distress, assessed against the same 11-criterion behavioral framework (impaired control, social impairment, risky use, pharmacological criteria); they differ chiefly in the pharmacology of the substance and, critically, in the danger profile of withdrawal.
Opioid Use Disorder often follows a period of legitimate prescribed use (e.g., for pain) that escalates, or begins with recreational use; Alcohol Use Disorder typically develops gradually against a backdrop of socially normative drinking, making early recognition harder for patients and families alike.
Both typically follow a chronic, relapsing course; opioid use disorder's course is often marked by more visible physiological dependence (tolerance, withdrawal) emerging relatively early, while alcohol use disorder's course can remain socially camouflaged for years before impairment becomes undeniable.
Opioid Use Disorder is associated with pinpoint pupils during use, constipation, and a high overdose-death risk from respiratory depression, especially with fentanyl-adulterated supply; Alcohol Use Disorder is associated with blackouts, hepatic and gastrointestinal disease, and a broader range of chronic organ damage.
Both cause significant functional impairment across occupational, social, and health domains; alcohol's legal and social availability often delays recognition of impairment compared to opioids, whose illegality (for non-prescribed use) tends to surface consequences sooner.
Neither diagnosis is made if the pattern of use is fully accounted for by appropriate use of a prescribed medication under medical supervision without the behavioral impairment criteria being met; both require ruling out that intoxication or withdrawal from the other substance is not the primary explanation for observed symptoms in a co-using patient.
The differential question is rarely which disorder is present -- the substances differ observably -- but rather assessing the safety-critical difference in withdrawal risk: opioid withdrawal is severely uncomfortable (flu-like symptoms, myalgia, GI distress) but is rarely medically lethal on its own, whereas alcohol withdrawal can progress to seizures and delirium tremens, which carry real mortality risk and require closer medical monitoring.
Learners sometimes assume all substance withdrawal syndromes carry comparable medical danger; conflating opioid and alcohol withdrawal risk can lead to under-monitoring of a patient in alcohol withdrawal or unnecessary alarm about a patient in opioid withdrawal.
A patient in obvious physical distress from stopping heavy drinking -- tremor, agitation, and especially any seizure or confusion -- signals alcohol withdrawal requiring urgent medical attention; a patient with severe myalgia, GI upset, and drug-seeking behavior after stopping opioids, without seizure risk, points to opioid withdrawal, which is typically managed for comfort rather than as a medical emergency.
| Feature | Opioid Use Disorder | Alcohol Use Disorder |
|---|---|---|
| Withdrawal lethality | Opioid: severely uncomfortable, rarely medically lethal alone | Alcohol: can be lethal (seizures, delirium tremens) |
| Legal status of use | Non-prescribed use is illegal | Legal for adults, socially normative |
| Overdose mechanism | Respiratory depression, often fentanyl-related | CNS depression, aspiration, organ toxicity |
A problematic pattern of opioid use leading to clinically significant impairment or distress, reflected in a cluster of behavioral, physiological, and craving-related symptoms occurring within a 12-month period.
A problematic pattern of alcohol use leading to clinically significant impairment or distress, assessed across a cluster of behavioral, physiological, and craving-related indicators within a 12-month period.